Hematology NewsTherapeutic dosing of busulfan helps reduce relapse in ASCTMarch 13, 2019TransplantationAggressive LymphomasLymphoma & Plasma Cell DisordersCellular Therapy
Hematology NewsAnti-CD45 conditioning looks safe, feasible in relapsed AMLMarch 13, 2019TransplantationAMLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsWeak evidence surrounds use of mesenchymal stem cellsMarch 12, 2019TransplantationCellular Therapy
Hematology NewsEngraftment achieved after conditioning without radiation, alkylating agentsMarch 7, 2019TransplantationCellular Therapy
Hematology TimesKD025 produces durable responses in patients with cGVHDMarch 7, 2019TransplantationPatient & Survivor CareCellular Therapy
Hematology NewsLentiviral gene therapy appears effective in X-CGDMarch 6, 2019TransplantationRare DiseasesCellular TherapyGene Therapy
Hematology NewsNovel transplant regimen improves survival in primary immunodeficiencyMarch 6, 2019TransplantationCellular TherapyTransfusion Medicine
Hematology NewsIxazomib targets treatment failure in chronic GVHDMarch 6, 2019TransplantationCellular Therapy
Oncology PracticeBarriers to CAR T use in the spotlight at first European meetingFebruary 28, 2019Immuno-oncologyImmunotherapyB Cell LymphomaAggressive LymphomasCellular TherapyBusiness of MedicineGene Therapy
Hematology NewsCLL, GVHD may raise risk for skin cancer after allo-HCTFebruary 28, 2019CLLTransplantationNonmelanoma Skin CancerLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsMidostaurin maintenance may reduce relapse risk in FLT3-ITD+ AMLFebruary 25, 2019TransplantationAMLLeukemia, Myelodysplasia, TransplantationCellular Therapy
Hematology NewsZUMA-1 update: Axi-cel responses persist at 2 yearsFebruary 24, 2019B Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsDual-targeted CAR T shows ‘clinical signal’ in NHLFebruary 24, 2019B Cell LymphomaMantle Cell LymphomaCellular TherapyTransplantationLymphoma & Plasma Cell DisordersImmuno-oncology
Hematology NewsAlloBMT should be option for older adults with hematologic malignanciesFebruary 24, 2019TransplantationCellular Therapy
Hematology NewsMRD negativity linked to survival in MM after auto-HCTFebruary 24, 2019TransplantationMultiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
